News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
73,926 Results
Type
Article (1927)
Company Profile (2)
Press Release (71991)
Section
Business (25333)
Career Advice (9)
Deals (4553)
Drug Development (8164)
FDA (1804)
Job Trends (799)
News (37024)
Policy (3561)
Tag
2027 BioCapital Standard (1)
Academia (99)
Accelerated approval (5)
ADA (2)
Allergies (25)
Alliances (8164)
ALS (21)
Alzheimer's disease (192)
Antibody-drug conjugate (ADC) (128)
Approvals (1985)
Artificial intelligence (40)
ASCO (37)
Autoimmune disease (41)
Automation (2)
Bankruptcy (9)
Best Places to Work (584)
BIO (9)
Biologics (1)
Biosimilars (101)
BioSpace Insights (1)
Biotechnology (5)
Bladder cancer (32)
Brain cancer (8)
Breast cancer (65)
Cancer (686)
Cardiovascular disease (28)
Career advice (9)
CAR-T (18)
CDC (2)
CDMO (9)
Celiac Disease (1)
Cell therapy (65)
Cervical cancer (5)
Clinical research (7790)
Collaboration (356)
Commercialization (5)
Compensation (28)
Complete response letters (7)
COVID-19 (200)
CRISPR (1)
C-suite (112)
Cystic fibrosis (9)
Data (920)
Depression (18)
Dermatology (14)
Diabetes (52)
Diagnostics (658)
Digital health (7)
Drug discovery (46)
Drug pricing (1)
Duchenne muscular dystrophy (49)
Earnings (8266)
Events (7669)
Executive appointments (81)
FDA (2366)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (171)
Gene editing (7)
Generative AI (1)
Gene therapy (43)
GLP-1 (87)
Government (246)
Grass and pollen (1)
Guidances (40)
Healthcare (1097)
Hematology (14)
HIV (7)
Huntington's disease (3)
IgA nephropathy (27)
Immunology and inflammation (7)
Immuno-oncology (12)
Indications (31)
Infectious disease (228)
Inflammatory bowel disease (25)
Inflation Reduction Act (1)
Influenza (14)
Intellectual property (44)
IPO (1641)
Job creations (241)
Job search strategy (9)
JPM (3)
Kidney cancer (2)
Kidney disease (6)
Layoffs (6)
Legal (953)
Licensing (15)
Liver cancer (22)
Longevity (3)
Lung cancer (131)
Lung diease (2)
Lymphoma (58)
Machine learning (1)
Manufacturing (152)
Marketing (5)
MASH (19)
Medical device (1174)
Medtech (1195)
Mergers & acquisitions (3127)
Metabolic disorders (127)
mRNA (8)
Multiple sclerosis (28)
NASH (1)
Neurodegenerative disease (39)
Neuropsychiatric disorders (7)
Neuroscience (369)
NextGen: Class of 2026 (219)
Non-profit (65)
Obesity (45)
Opinion (1)
Ovarian cancer (35)
Pain (22)
Pancreatic cancer (33)
Parkinson's disease (51)
Partnered (4)
Patents (80)
Patient recruitment (92)
Patient selection (6)
Peanut (2)
People (5228)
Peptides (1)
Pharmaceutical (2)
Pharmacy benefit managers (5)
Phase 1 (2102)
Phase 2 (3304)
Phase 3 (2938)
Pipeline (1463)
Policy (1)
Postmarket research (241)
Preclinical (712)
Press Release (2)
Prostate cancer (29)
Radiopharmaceuticals (29)
Rare diseases (95)
Real estate (606)
Regenerative medicine (1)
Regulatory (3122)
Reports (9)
Research institute (97)
Rett syndrome (1)
RNA editing (3)
RSV (3)
Schizophrenia (25)
Series A (37)
Series B (25)
Service/supplier (1)
Sickle cell disease (8)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (425)
Stomach cancer (2)
Substance use disorders (2)
Supply chain (14)
Vaccines (48)
Venture capital (7)
Weight loss (20)
Women's health (8)
Date
Last 7 days (64)
Last 30 days (225)
Last 365 days (2844)
2026 (2169)
2025 (2684)
2024 (3252)
2023 (3820)
2022 (7001)
2021 (6372)
2020 (5872)
2019 (3858)
2018 (3013)
2017 (3558)
2016 (3171)
2015 (4029)
2014 (3020)
2013 (2600)
2012 (2775)
2011 (2902)
2010 (2663)
Location
Africa (88)
Alabama (5)
Arizona (14)
Arkansas (1)
Asia (22391)
Australia (2500)
California (878)
Canada (502)
China (561)
Colorado (5)
Connecticut (29)
Delaware (9)
Europe (13583)
Florida (97)
Georgia (18)
Hawaii (1)
Illinois (47)
India (63)
Indiana (33)
Japan (375)
Kansas (5)
Louisiana (2)
Maine (4)
Maryland (137)
Massachusetts (699)
Michigan (9)
Minnesota (40)
Missouri (3)
Nebraska (3)
Nevada (14)
New Hampshire (1)
New Jersey (550)
New York (303)
North Carolina (133)
Northern California (379)
Ohio (7)
Oregon (1)
Pennsylvania (166)
Puerto Rico (1)
Rhode Island (1)
South America (109)
South Carolina (1)
Southern California (432)
Tennessee (6)
Texas (66)
United States (3380)
Utah (35)
Vermont (1)
Virginia (68)
Washington D.C. (3)
Washington State (64)
Wisconsin (8)
Wyoming (1)
73,926 Results for "chemomab ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Chemomab Therapeutics to Present at H.C. Wainwright 28th Annual Global Investor Conference
August 31, 2026
·
9 min read
Press Releases
Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update
August 19, 2026
·
19 min read
Press Releases
Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update
May 14, 2026
·
15 min read
Press Releases
Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis
July 8, 2026
·
21 min read
Press Releases
Chemomab Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 17, 2026
·
1 min read
Press Releases
Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update
March 19, 2026
·
16 min read
Press Releases
Chemomab to Participate in Oppenheimer’s Movers in Rare Disease Summit 2025
November 24, 2025
·
2 min read
Press Releases
Chemomab Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update
November 21, 2025
·
12 min read
Press Releases
Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK
August 31, 2026
·
2 min read
Press Releases
Chemomab Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference
August 22, 2025
·
2 min read
1 of 7,393
Next
